A strategy for enhancing the transcriptional activity of weak cell type-specific promoters

被引:63
作者
Nettelbeck, DM [1 ]
Jérôme, V [1 ]
Müller, R [1 ]
机构
[1] Univ Marburg, Inst Mol Biol & Tumorforsch, D-35033 Marburg, Germany
关键词
tissue-specific promoters; endothelial cell-specific transcription; von Willebrand factor promoter; gastrointestinal-specific transcription; sucrase isomaltase promoter; transcriptional targeting;
D O I
10.1038/sj.gt.3300778
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cell type- and tissue-specific promoters play an important role in the development of site-selective vectors for gene therapy. A large number of highly specific promoters has been described, but their applicability is often hampered by their inefficient transcriptional activity. In this study, we describe a new strategy for enhancing the activity of weak promoters without loss of specificity. The basic principle of this strategy is to establish a positive feedback loop which is initiated by transcription from a cell type-specific promoter. This was achieved by using a cell type-specific promoter to drive the simultaneous expression of the desired effector/reporter gene product and a strong artificial transcriptional activator which stimulates transcription through appropriate binding sites in the promoter. Using a VP16-LexA chimeric transcription factor, we show that this approach leads to a 14- to > 100-fold enhancement of both and the gastrointestinal-specific sucrase-isomaltase promoter while maintaining approximately 30- to > 100-fold cell type specificity.
引用
收藏
页码:1656 / 1664
页数:9
相关论文
共 42 条
[1]   A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: Polyethylenimine [J].
Abdallah, B ;
Hassan, A ;
Benoist, C ;
Goula, D ;
Behr, JP ;
Demeneix, BA .
HUMAN GENE THERAPY, 1996, 7 (16) :1947-1954
[2]  
Almendro N, 1996, J IMMUNOL, V157, P5411
[3]   In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector [J].
Arbuthnot, PB ;
Bralet, MP ;
LeJossic, C ;
Dedieu, JF ;
Perricaudet, M ;
Brechot, C ;
Ferry, N .
HUMAN GENE THERAPY, 1996, 7 (13) :1503-1514
[4]  
BEAN MA, 1975, CANCER RES, V35, P2902
[5]   A EUKARYOTIC TRANSCRIPTIONAL ACTIVATOR BEARING THE DNA SPECIFICITY OF A PROKARYOTIC REPRESSOR [J].
BRENT, R ;
PTASHNE, M .
CELL, 1985, 43 (03) :729-736
[6]   Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter [J].
Chen, L ;
Chen, DS ;
Manome, Y ;
Dong, YH ;
Fine, HA ;
Kufe, DW .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (06) :2775-2782
[7]  
DACHS GU, 1997, NAT MED, V3, P5515
[8]   Evaluation of GAL4/TATA in vivo -: Induction of transgene expression by adenovirally mediated gene codelivery [J].
Fang, BL ;
Ji, L ;
Bouvet, M ;
Roth, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (09) :4972-4975
[9]   THE ROLE OF THE 5'-FLANKING REGION IN THE CELL-SPECIFIC TRANSCRIPTION OF THE HUMAN VON-WILLEBRAND-FACTOR GENE [J].
FERREIRA, V ;
ASSOULINE, Z ;
SCHWACHTGEN, JL ;
BAHNAK, BR ;
MEYER, D ;
KERBIRIOUNABIAS, D .
BIOCHEMICAL JOURNAL, 1993, 293 :641-648
[10]   Characterization of the human platelet endothelial cell adhesion molecule-1 promoter: Identification of a GATA-2 binding element required for optimal transcriptional activity [J].
Gumina, RJ ;
Kirschbaum, NE ;
Piotrowski, K ;
Newman, PJ .
BLOOD, 1997, 89 (04) :1260-1269